Adelmidrol: A New Promising Antioxidant and Anti-Inflammatory Therapeutic Tool in Pulmonary Fibrosis

Adelmidrol: A New Promising Antioxidant and Anti-Inflammatory Therapeutic Tool in Pulmonary Fibrosis

Background: Chronic pulmonary diseases are characterized by airway remodeling due to complex multicellular responses and the production of free oxygen radicals. They lead to a progressive decline of pulmonary functions. Adelmidrol is an analogue of palmitoylethanolamide (PEA), which is a well-known...

Full description

Bibliographic Details
Main Authors: Roberta Fusco, Marika Cordaro, Tiziana Genovese, Daniela Impellizzeri, Rosalba Siracusa, Enrico Gugliandolo, Alessio Filippo Peritore, Ramona D’Amico, Rosalia Crupi, Salvatore Cuzzocrea, Rosanna Di Paola
Format: Article
Language:English
Published: MDPI AG 2020-07-01
Series:Antioxidants
Subjects:
oxidative stress
pulmonary fibrosis
biochemistry
Online Access:https://www.mdpi.com/2076-3921/9/7/601

Internet

https://www.mdpi.com/2076-3921/9/7/601

Similar Items